As of May 22
| +1.00 / +2.64%|
The 2 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 50.50, with a high estimate of 55.00 and a low estimate of 46.00. The median estimate represents a +29.72% increase from the last price of 38.93.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.